Pretransplant Immunosuppression for Glomerulonephritis Ups Malignancy Risk
Patients receiving significant amount of immunosuppression prior to kidney transplantation should be counseled on these malignancy risks, according to investigators.
Patients receiving significant amount of immunosuppression prior to kidney transplantation should be counseled on these malignancy risks, according to investigators.
Study findings support The End-Stage Renal Disease Quality Incentive Program’s composite measure of facility performance, which is revised annually.
The new equation appears more accurate than the race-free 2021 CKD-EPI equation, according to investigators.
An analysis of US data revealed that patients with end-stage kidney disease admitted to a hospital on a weekend vs a weekday are 8% more likely to die in the hospital.
Black patients without high-risk APOL1 alleles did not have higher risks for kidney failure.
Patients with advanced CKD have not been well-represented in trials evaluating intensive blood pressure control.
Testing for coronary heart disease before kidney transplantation is common practice, but may not be warranted for all patients, according to investigators.
GDF-15 adds predictive value to the HAS-BLED score for assessing major bleeding risk.
The OPTN policy revision may increase some Black kidney candidates’ total waiting time, which is a major factor in their transplant priority for organ offers.
Current kidney decision aids for patients focus on dialysis and do not address the unique needs of older patients.